Edison Investment Research

Agennix AG

Sepsis trial stopped

Update | Pharmaceutical & Healthcare | 03/02/2012

Agennix has stopped the Phase II/III OASIS trial, following the advice of the study Data Safety Monitoring Board (DSMB). It had observed that the 28-day…

MagForce

Nanomedicine player

QuickView | Pharmaceutical & Healthcare | 03/02/2012

MagForce is aiming to raise €4.5m through a shareholder rights issue to support the next phase in commercialising its NanoTherm therapy. NanoTherm…

Sangamo BioSciences

Genome editor

QuickView | Pharmaceutical & Healthcare | 03/02/2012

Sangamo shares gained 21% following the announcement of a significant deal with Shire to research novel approaches to treat haemophilia and other monogenic…

Wits Gold

Cheap acquisition

Update | Mining | 03/02/2012

Since the arrival of CEO Philip Kotze on 1 August 2011, Wits Gold has redefined its strategies on exploration and project building to include acquisitions.…

Amur Minerals Corporation

District scale nickel?

Outlook | Mining | 03/02/2012

While Amur pursues final approval for its Kun-Manie mining licence with the Russian authorities, recent exploration results achieved over its lease area…

More research

Slater & Gordon

Common law partners

Update | Consumer Support Services | 03/02/2012

Lo-Q

Virtual queuing innovator

Outlook | Technology | 03/02/2012

Newmark Security

International potential

Review | Industrial Support Services | 03/02/2012

ProMetic Life Sciences

Revenue receipts roll in

Update | Pharmaceutical & Healthcare | 03/02/2012

Mondo TV

Tough times

Update | Media & Entertainment | 03/02/2012

Walker Greenbank

Amazing year

Update | General Industrials | 03/02/2012

Avon Rubber

Filtering opportunities

Update | Aerospace & Defence | 03/02/2012

Mattioli Woods

Investing for growth

QuickView | Financials | 02/02/2012

Matchtech Group

All eyes on perm

Update | Consumer Support Services | 02/02/2012